A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary CholangitisFrederik Nevens, Д. А. Шапиро, Pietro Andreoné et al.|New England Journal of Medicine|2016Cited by 1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis WorseningVlad Ratziu, Velimir A. Luketic, Juan F. Gallegos‐Orozco et al.|Gastroenterology|2016Cited by 1k
United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)Matthias Löhr, Thomas L. Bollen, Marco J. Bruno et al.|United European Gastroenterology Journal|2017Cited by 698
Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disordersJoost P.H. Drenth, Stephen G. Waxman|Journal of Clinical Investigation|2007Cited by 362
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitisHeiko Witt, Thomas Berg, Miklós Sahin‐Tóth et al.|Nature Genetics|2006Cited by 250